Feature

Deconstructing MACRA: the switch from volume- to value-based payment

Author and Disclosure Information

 

In this interview, Dr Bosserman and Dr Zon talk aboout the ins and outs of the upcoming implementation of MACRA, the Medicare Access and CHIP Reauthorization Act of 2015. The legislation will usher in the switch from volume- to value- and performance-based Medicare payments. It goes into effect in January 2019, but the measurements will be based on 2017 performance. Dr Zon lists five steps for preparing for MACRA: first, participate in the three 2016 quality-reporting programs – PQRS, meaningful use, and VBM – to avoid 2018 penalties; second, review your Quality and Resource Use Reports, or QRUR, which are available online; third, focus on performance by reviewing quality benchmarks and implementing strategies and workflows to ensure above-average performance; fourth, ensure data and information accuracy, eg, physician specialty and practice address; and fifth, audit and educate your practice on proper use of the International Classification of Diseases, Revision 10 coding.

For more, listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interveiw.

Recommended Reading

Mindfulness-based cancer recovery in survivors recovering from chemotherapy and radiation
MDedge Hematology and Oncology
1,25-dihydroxyvitamin D hypercalcemia and imatinib hepatotoxicity in a patient with GIST
MDedge Hematology and Oncology
Proper treatment of herpes zoster ‘a work in progress’
MDedge Hematology and Oncology
Extended-release granisetron superior antiemetic for cisplatin chemotherapy
MDedge Hematology and Oncology
Pneumonitis with nivolumab treatment shows common radiographic patterns
MDedge Hematology and Oncology
Whole brain radiotherapy not beneficial for NSCLC metastasis
MDedge Hematology and Oncology
Low caregiver self-care linked with depression, anxiety
MDedge Hematology and Oncology
Dental oncology in patients treated with radiation for head and neck cancer
MDedge Hematology and Oncology
A positive attitude in prostate cancer challenges: finding hope and optimism
MDedge Hematology and Oncology
Dexamethasone-associated posterior reversible encephalopathy syndrome
MDedge Hematology and Oncology